Postmarketing pharmacovigilance: Remdesivir and cardiovascular events. | Clin Transl Sci;15(4): 813-815, 2022 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events.

Sullivan, John T.

Sullivan JT; Retired.

Clin Transl Sci ; 15(4): 813-815, 2022 04.

Article in English | MEDLINE | ID: covidwho-1816543

Subject(s)

Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Adenosine Monophosphate/adverse effects; Adenosine Monophosphate/analogs & derivatives; Alanine/adverse effects; Alanine/analogs & derivatives; Cardiovascular Diseases/chemically induced; Humans; Pharmacovigilance; Product Surveillance, Postmarketing

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / Drug-Related Side Effects and Adverse Reactions Limits: Humans Language: English Journal: Clin Transl Sci Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / Drug-Related Side Effects and Adverse Reactions Limits: Humans Language: English Journal: Clin Transl Sci Year: 2022 Document Type: Article